Altos Labs
altoslabs.comOperator of a biotechnology company intended to restore cell health and resilience with the goal of reversing disease, injury, and disabilities.
LBX PPS
1Y return
$18.00
↓ 28.1% 1Y
Implied Valuation
$6.3B
-28.1% premium
Last Round
Feb 2024
$25.02
PE Growth/Expansion · $8.8B
Activity
1.7
#117 most active
Price per share
12M · USD
Loading chart...
Funding history
$M raised · $B post-money
Loading chart...
Explore related companies
More company profiles from the LBX Pro directory.